Who Paid My Doc
Chihiro Morishima
Clinical & Laboratory Immunology Seattle, WA Medical Doctor
NPI 1295077287 CMS profile 285116
1959 Ne Pacific St, Seattle, WA 98195
General payments
$25,292
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Chihiro Morishima of Seattle, WA is reported in the CMS Open Payments database as having received $25,292 across 34 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,860 | 4 | |
| 2024 | General | $1,862 | 4 | |
| 2023 | General | $3,414 | 7 | |
| 2022 | General | $1,029 | 2 | |
| 2021 | General | $5,522 | 6 | |
| 2020 | General | $5,106 | 5 | |
| 2019 | General | $6,500 | 6 |
Beside peers
- Chihiro Morishima
- Washington median
- Middle half of Washington
- National median
In program year 2025, general payments to Chihiro Morishima were reported at $1,860. Among 15,799 Washington profiles paid that year, the median was $133 and the middle half received between $42 and $442.
Show as a table
| Year | Chihiro Morishima | Washington median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $6,500 | $126 | $38–$506 | $163 |
| 2020 | $5,106 | $90 | $30–$291 | $114 |
| 2021 | $5,522 | $107 | $29–$344 | $132 |
| 2022 | $1,029 | $124 | $38–$398 | $149 |
| 2023 | $3,414 | $129 | $40–$423 | $160 |
| 2024 | $1,862 | $133 | $44–$454 | $164 |
| 2025 | $1,860 | $133 | $42–$442 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 4 billing codesPaid by Medicare
$30,732
Medicare patients
917
Services billed
2,138
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 70% | |
| Arthritis | 42% | |
| Chronic kidney disease | 35% | |
| Ischemic heart disease | 28% | |
| Heart failure | 25% | |
| Osteoporosis | 25% | |
| Atrial fibrillation | 24% | |
| Depression | 22% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
34 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical & Laboratory Immunology in Washington
Related records
Clinical & Laboratory Immunology in Washington
Practitioners in the same specialty and state, ranked by reported value.
All Clinical & Laboratory Immunology
Everyone recorded under this specialty, nationwide.
Doctors in Washington
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.